Epizyme Inc (EPZM) Stock Loses -14.91% This Week; Should You Buy?
Wednesday, November 17, 2021 01:46 PM | InvestorsObserver Analysts
Mentioned in this article
Epizyme Inc (EPZM) stock has fallen -64.29% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives EPZM stock a score of 35 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 3. EPZM's rank also includes a long-term technical score of 6. The fundamental score for EPZM is 95. In addition to the average rating from Wall Street analysts, EPZM stock has a mean target price of $11.00. This means analysts expect the stock to climb 167.64% over the next 12 months.
EPZM has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on EPZM!
Epizyme Inc (EPZM) stock is down -3.8% while the S&P 500 has fallen -0.18% as of 1:44 PM on Wednesday, Nov 17. EPZM has fallen -$0.16 from the previous closing price of $4.27 on volume of 591,123 shares. Over the past year the S&P 500 has risen 30.00% while EPZM has fallen -64.29%. EPZM lost -$2.62 per share in the over the last 12 months.
Click Here to get the full Stock Report for Epizyme Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
